Atlas Trials

Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®

Clinical trial NCT01937299 · COMPLETED

Trial details

NCT number
NCT01937299
Sponsor
Alcon Research
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Ocular HypertensionOpen Angle Glaucoma
Start date
2013-10-01
Primary completion
2014-04-01
Enrollment
307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.